The SPAN survey underscores gaps in schizophrenia care access as new treatments emerge, citing coverage and continuity challenges.
Schizophrenia & Psychosis Action Alliance
Latest Content
A new study reveals the overwhelming financial and emotional burdens faced by caregivers of individuals with schizophrenia, highlighting urgent support needs.
The FDA's removal of clozapine REMS enhances access to treatment, while new educational initiatives empower clinicians to improve patient care.
Advertisement
Advertisement
Trending on Psychiatric Times
1
New Positive Phase 2 Topline Data on Elunetirom for the Treatment of Bipolar Depression
2
Suicide Risk Assessment in Patients Denying Suicidal Intent
3
Podcast: Early Intervention & Psychopharmacology in Bipolar Disorder With Robert M. Post, MD
4
AI-Driven Biomarker Discovery from Wearables in Neuropsychiatric Research
5